Technology Commercialization
Drug Valuation
- Program Objective
- To conduct quantitative valuation of drug assets and provide benchmarks for technology transactions, minimizing information gaps between parties and facilitating timely L/o. To provide strategic guidance on future drug development strategy using insights derived from the valuation outcomes.
- Program Details
Program Period: Mar-Nov, 2026 (Project starts in Q1 and ends in Q4 every year.)
- Procedure:
① Selection of executing organization
② Application and selection of target projects
③ Kick-off meeting
④ Project execution (meetings between executing and lead research institutions, data requests, internal reviews, etc.)
⑤ Derivation of final valuation results.
⑥ Post-valuation consulting based on results
- Contact
Business Development Team: kddf_bd@kddf.org